Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Keuzehulp ondersteunt samen beslissen en therapietrouw
apr 2019 | Multipele Sclerose